The research plan identifies and examines opportunities to increase scientific understanding of lupus, which will ultimately lead to safer and more effective treatments and, eventually, curative strategies
The Agenda for Lupus identifies public health priorities, strategies and recommendations for efforts in lupus biomedical research and clinical care.
Grant provides an unprecedented opportunity to further build out meaningful programs and services for people with lupus and physicians.
The Lupus Foundation of America research grants will support important studies on immune cells, pediatric lupus, stem cells, biomarkers, and environmental triggers of lupus.
A new Congressional report includes an article contributed by the Lupus Foundation of America on health disparities among people with lupus and current efforts to improve treatment and diagnosis in minority communities.
Lupus Foundation of America’s Collaboration in PARTNERS Seeks to Improve Pediatric Research and Care
Learn more about PARTNERS (Patients, Advocates and Rheumatology Teams Network for Research and Service), a new initiative.
Foundation-funded research studies highlighted at premier rheumatology meeting in Boston.
Sandra C. Raymond, President & CEO of the Lupus Foundation of America, issued the following statement in response to Eli Lilly and Company’s announcement of the results of two Phase III clinical trials of tabalumab.